Investigational Drug Information for Linzagolix
✉ Email this page to a colleague
What is the development status for investigational drug Linzagolix?
Linzagolix is an investigational drug.
There have been 6 clinical trials for Linzagolix.
The most recent clinical trial was a Phase 1 trial, which was initiated on June 13th 2019.
The most common disease conditions in clinical trials are Endometriosis, Liver Diseases, and Renal Insufficiency. The leading clinical trial sponsors are ObsEva SA and [disabled in preview].
There is one US patent protecting this investigational drug and twenty-eight international patents.
Summary for Linzagolix
| US Patents | 1 |
| International Patents | 28 |
| US Patent Applications | 31 |
| WIPO Patent Applications | 15 |
| Japanese Patent Applications | 6 |
| Clinical Trial Progress | Phase 1 (2019-06-13) |
| Vendors | 23 |
Recent Clinical Trials for Linzagolix
| Title | Sponsor | Phase |
|---|---|---|
| Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain | ObsEva SA | Phase 3 |
| Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain (EDELWEISS 6) | ObsEva SA | Phase 3 |
| Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain. | ObsEva SA | Phase 3 |
Clinical Trial Summary for Linzagolix
Top disease conditions for Linzagolix
Top clinical trial sponsors for Linzagolix
US Patents for Linzagolix
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Linzagolix | ⤷ Sign Up | Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof | KISSEI PHARMACEUTICAL CO., LTD. (Nagano, JP) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Linzagolix
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Linzagolix | Australia | AU2006305271 | 2025-10-19 | ⤷ Sign Up |
| Linzagolix | Brazil | BRPI0617436 | 2025-10-19 | ⤷ Sign Up |
| Linzagolix | Canada | CA2624492 | 2025-10-19 | ⤷ Sign Up |
| Linzagolix | China | CN101331134 | 2025-10-19 | ⤷ Sign Up |
| Linzagolix | Cyprus | CY1113898 | 2025-10-19 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
